The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.
Vaccines, Blood & Biologics
Public Workshop - The Development and Evaluation of Next-Generation Smallpox Vaccines
Date and Time: The public workshop will be held on September 16, 2011, from 8 a.m. to 5:30 p.m.
Location: The public workshop will be held at the Hilton Washington DC North/Gaithersburg, 620 Perry Pkwy., Gaithersburg, MD 20877.
The Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER) and the National Institutes of Health, the National Institute of Allergy and Infectious Diseases are announcing a public workshop entitled "The Development and Evaluation of Next-Generation Smallpox Vaccines." The purpose of the public workshop is to identify and discuss the key issues related to the development and evaluation of next-generation smallpox vaccines. The public workshop will include presentations on the human response to smallpox vaccines and development of animal models for demonstration of effectiveness of next-generation smallpox vaccines.
Contact Person: Bernadette Williamson-Taylor, Center for Biologics Evaluation and Research (HFM-43), Food and Drug Administration, 1401 Rockville Pike, suite 200N, Rockville, MD 20852-1448, 301-827-2000, FAX: 301-827-3079, email: CBERTraining@fda.hhs.gov (in the subject line type "Smallpox Workshop").
Registration: Mail, fax, or email your registration information (including name, title, firm name, address, telephone, and fax numbers) to the contact person by August 23, 2011. There is no registration fee for the public workshop. Early registration is recommended because seating is limited. Registration on the day of the public workshop will be provided on a space available basis beginning at 7:30 a.m.
If you need special accommodations due to a disability, please contact Bernadette Williamson-Taylor (see Contact Person) at least 7 days in advance.